Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Pediatric sleep pharmacology

Pelayo R, Yuen K.

Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):861-83. doi: 10.1016/j.chc.2012.08.001.

Current treatment of selected pediatric sleep disorders

Sullivan SS.

Neurotherapeutics. 2012 Oct;9(4):791-800. doi: 10.1007/s13311-012-0149-2.

A phase II, open-label, non-comparative study of Botulinum toxin in Restless Legs Syndrome

Ghorayeb I, Bénard A, Vivot A, Tison F, Burbaud P.

Sleep Med. 2012 Dec;13(10):1313-6. doi: 10.1016/j.sleep.2012.08.019. Epub 2012 Oct 11.

Intravenous iron given prior to pregnancy for restless legs syndrome is associated with remission of symptoms

Picchietti DL, Wang VC, Picchietti MA.

J Clin Sleep Med. 2012 Oct 15;8(5):585-6. doi: 10.5664/jcsm.2168.

Uremic versus idiopathic restless legs syndrome: impact on aspects related to quality of life

Gkizlis V, Giannaki CD, Karatzaferi C, Hadjigeorgiou GM, Mihas C, Koutedakis Y, Stefanidis I, Sakkas GK.

ASAIO J. 2012 Nov-Dec;58(6):607-11. doi: 10.1097/MAT.0b013e31826d6090.

Multiple sclerosis and restless legs syndrome: a systematic review and meta-analysis

Schürks M, Bussfeld P.

Eur J Neurol. 2013 Apr;20(4):605-15. doi: 10.1111/j.1468-1331.2012.03873.x. Epub 2012 Oct 18.

Iron and attention deficit/hyperactivity disorder: What is the empirical evidence so far? A systematic review of the literature

Cortese S, Angriman M, Lecendreux M, Konofal E.

Expert Rev Neurother. 2012 Oct;12(10):1227-40. doi: 10.1586/ern.12.116.

In adults with Restless Legs Syndrome, which treatments have been found to be effective?

Myrick L, Tress R, Mold JW, Welborn TL.

J Okla State Med Assoc. 2012 Aug;105(8):313-5.

Physostigmine and restless legs syndrome

Peacock J, Mishra G, Roy RC.

Anesthesiology. 2012 Nov;117(5):1144-5. doi: 10.1097/ALN.0b013e31826e7038.

Pediatric sleep-wake disorders

Kotagal S, Chopra A.

Neurol Clin. 2012 Nov;30(4):1193-212. doi: 10.1016/j.ncl.2012.08.005.

Sleep, stroke and poststroke

Culebras A.

Neurol Clin. 2012 Nov;30(4):1275-84. doi: 10.1016/j.ncl.2012.08.017. Epub 2012 Sep 15.

Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome

Inoue Y, Hirata K, Hayashida K, Hattori N, Tomida T, Garcia-Borreguero D; Rotigotine Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jan 10;40:326-33. doi: 10.1016/j.pnpbp.2012.10.012. Epub 2012 Oct 25.

Treatment for Restless Legs Syndrome

Wilt TJ, MacDonald R, Ouellette J, Tacklind J, Khawaja I, Rutks I, Butler M, Fink HA.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Nov. Report No.: 12(13)-EHC147-EF.

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study

Inoue Y, Hirata K, Uchimura N, Kuroda K, Hattori N, Takeuchi M.

Curr Med Res Opin. 2013 Jan;29(1):13-21. doi: 10.1185/03007995.2012.746217. Epub 2012 Nov 30.

Drugs associated with restless legs syndrome: a case/noncase study in the French Pharmacovigilance Database

Perez-Lloret S, Rey MV, Bondon-Guitton E, Rascol O, Montastruc AJ; French Association of Regional Pharmacovigilance Centers.

J Clin Psychopharmacol. 2012 Dec;32(6):824-7. doi: 10.1097/JCP.0b013e318272cdd8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias